Sign In
Buy NOV
$19.06
-0.760 (-3.83%)
At Close: Jul 29, 2026
Nov Inc. (NOV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
06:01pm, Wednesday, 29'th Jul 2026
Although the revenue and EPS for Nov Inc. (NOV) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street e
NOV Inc. (NOV) Q2 2026 Earnings Call Transcript
02:43pm, Wednesday, 29'th Jul 2026
NOV Inc. (NOV) Q2 2026 Earnings Call Transcript
Nov Inc. (NOV) Q2 Earnings and Revenues Beat Estimates
08:30pm, Tuesday, 28'th Jul 2026
Nov Inc. (NOV) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.29 per share a year ago.
NOV Reports Second Quarter 2026 Earnings
05:45pm, Tuesday, 28'th Jul 2026
Revenues of $2.13 billion, up 4% sequentially and down 2% year-over-year Net income of $112 million, or $0.31 per share, an increase of $93 million sequentially and $4 million year-over-year Adjusted
NOV to Report Q2 Earnings: What's in Store for the Stock?
12:31pm, Friday, 24'th Jul 2026
NOV faces a key Q2 test as delayed shipments, strong order trends and cost cuts collide with ongoing logistics and drilling headwinds.
Nov Inc. (NOV) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:06am, Tuesday, 21'st Jul 2026
Nov Inc. (NOV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NOV Stock Rallies 49% in a Year: Time to Buy or Move On?
11:01am, Tuesday, 14'th Jul 2026
NOV's technology gains, rising earnings estimates, strong backlog and shareholder returns strengthen its long-term outlook despite trailing some peers.
NOV vs. SLB N.V.: Which Energy Stock Is a Better Buy in 2026?
09:55pm, Saturday, 27'th Jun 2026
NOV provides a conservative balance sheet with a current ratio of roughly 2.4x and low debt levels. SLB N.V. leverages a massive global footprint to generate substantial free cash flow nearing $4.8 bi
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn's Disease
04:05pm, Tuesday, 23'rd Jun 2026
-- Regulatory alignment with U.S. Food and Drug Administration (FDA) on key elements of NOV-ERA Phase 2b study design, including novel primary endpoint of endoscopic passability -- -- Study initiation
NOV Announces Second Quarter 2026 Earnings Conference Call
06:30am, Tuesday, 16'th Jun 2026
HOUSTON, June 16, 2026 (GLOBE NEWSWIRE) -- NOV Inc. (NYSE: NOV) will hold a conference call to discuss its second quarter 2026 results on Wednesday, July 29, 2026, at 10 a.m. (Central Time).
NOV Stock Gains 32% in Six Months: Should Investors Hold or Move On?
09:36am, Tuesday, 09'th Jun 2026
NOV shares rise 32% over the past six months as offshore demand, backlog growth and efficiency gains boost prospects despite tariffs and risks.
Why Is Nov Inc. (NOV) Up 4.1% Since Last Earnings Report?
12:31pm, Wednesday, 27'th May 2026
Nov Inc. (NOV) reported earnings 30 days ago. What's next for the stock?
NOV Declares Regular Quarterly Dividend and Supplemental Dividend
06:30am, Thursday, 21'st May 2026
HOUSTON, May 21, 2026 (GLOBE NEWSWIRE) -- NOV Inc. (NYSE: NOV) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock, payable on Jun
Solaris Energy Q1 Earnings Crush Estimates on Power Growth
09:36am, Monday, 04'th May 2026
SEI's Q1 profit jumped 120%, and revenues rose 55% as Power Solutions scaled, aided by behind-the-meter data center power demand.
NOV Q1 Earnings Miss Estimates, Revenues Beat, Decrease Y/Y
09:05am, Friday, 01'st May 2026
NOV Q1 earnings miss estimates as Middle East disruptions hit operations, while revenues edge past expectations despite a year-over-year decline.
